Compounded Tirzepatide
Tirzepatide
Compounded tirzepatide is a dual GIP and GLP-1 receptor agonist prepared by a licensed compounding pharmacy. It targets two metabolic pathways to reduce appetite and support weight loss — administered as a once-weekly subcutaneous injection.
How Tirzepatide works
Tirzepatide is a dual GIP and GLP-1 receptor agonist. By activating both incretin pathways, it reduces appetite, slows gastric emptying, and improves how your body regulates blood sugar. When paired with clinician guidance, this combined effect can support sustained weight loss.
Dual-agonist action
Targets both GIP and GLP-1 pathways that help regulate appetite and metabolism.
Appetite reduction
Helps you feel fuller with less and reduces cravings, supporting adherence to a nutrition plan.
Once-weekly dosing
A single subcutaneous injection each week, titrated to your tolerance and clinical response.
Improved metabolic markers
Supports blood sugar control and favorable changes in body composition alongside weight loss.
Your clinician-guided program
Every plan is built around your health history, labs, and goals — and supervised by a licensed clinician throughout.
- Secure video consultation with a licensed clinician
- Personalized treatment plan and prescription, if appropriate
- Medication shipped from our partner pharmacy (Rush Pharmacy)
- Ongoing clinician check-ins and plan adjustments
- Lab orders and results reviewed with you
Common questions
See if Tirzepatide is right for you
Order now to connect with a licensed clinician. Your plan and any prescription are decided during your visit.
Order Now